Athletech News looks at who fitness clients are turning to when they have questions about peptides, shared by Mark A. McKenney.
Recap by typeshit. Post by Mark A. McKenney on X.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Piotr Alvarez lays out a three-stage outlook for AI in peptide method development, and the panel argues scientists keep the final judgment as conjugates get more complex.
NPR reports on the growing pile of lawsuits claiming serious side effects, and what they raise about how often those harms actually happen.
Loading…